- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4743 - QuinolinesIsoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
Patent holdings for IPC class A61K 31/4743
Total number of patents in this class: 102
10-year publication summary
|
4
|
6
|
1
|
7
|
5
|
8
|
7
|
7
|
6
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21310 |
6 |
| Symrise AG | 1851 |
4 |
| Bristol-myers Squibb Company | 4748 |
3 |
| Arbutus Biopharma Corporation | 161 |
3 |
| Novartis AG | 10178 |
2 |
| Amgen Inc. | 4436 |
2 |
| Korea Institute of Science and Technology | 2255 |
2 |
| Case Western Reserve University | 1898 |
2 |
| Chugai Seiyaku Kabushiki Kaisha | 1421 |
2 |
| FibroGen, Inc. | 74 |
2 |
| Genzyme Corporation | 1373 |
2 |
| Hanmi Holdings Co., Ltd | 20 |
2 |
| Hanmi Pharmaceutical Co. Ltd. | 32 |
2 |
| KG Acquisition LLC | 3 |
2 |
| Oricula Therapeutics LLC | 2 |
2 |
| PTC Therapeutics, Inc. | 473 |
2 |
| Shionogi & Co., Ltd. | 885 |
2 |
| Trana Discovery, Inc. | 14 |
2 |
| University of Washington | 2451 |
2 |
| Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 138 |
2 |
| Other owners | 54 |